ArticleBMC musculoskeletal disorders2021

Anti-IL17 antibody Secukinumab therapy is associated with ossification in giant cell tumor of bone: a case report of pathologic similarities and therapeutic potential similar to Denosumab.

Andrew Chandler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.